James B Canavan
Overview
Explore the profile of James B Canavan including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
20
Citations
694
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Rodger B, Clough J, Vasconcelos J, Canavan J, Macallan D, Prevost A, et al.
BMJ Open
. 2025 Jan;
15(1):e092733.
PMID: 39855667
Introduction: Crohn's disease (CD) is a chronic, immune-mediated inflammatory bowel disease (IBD), presenting with symptoms of abdominal pain and bleeding from the gastrointestinal tract. There is no known cure. In...
2.
Yang M, Usiskin K, Ahmad H, Ather S, Sreih A, Canavan J, et al.
Dig Dis
. 2023 Sep;
42(1):12-24.
PMID: 37757769
Background: High-quality colonoscopic surveillance can lead to earlier and increased detection of colorectal neoplasia in patients with inflammatory bowel disease (IBD). In IBD clinical trials, endoscopy is used to assess...
3.
Danese S, Panaccione R, Abreu M, Rubin D, Ghosh S, Dignass A, et al.
J Crohns Colitis
. 2023 Aug;
18(2):264-274.
PMID: 37651686
Backgrounds And Aims: This interim analysis from the True North open-label extension [OLE] study examines efficacy and safety of approximately 3 years of continuous ozanimod treatment in patients with moderately...
4.
Ahmad H, East J, Panaccione R, Travis S, Canavan J, Usiskin K, et al.
Intest Res
. 2023 Apr;
21(3):283-294.
PMID: 37075809
Inflammatory bowel disease encompasses Crohn's disease and ulcerative colitis and is characterized by uncontrolled, relapsing, and remitting course of inflammation in the gastrointestinal tract. Artificial intelligence represents a new era...
5.
Allegretti J, Mitsialis V, Canavan J, Snapper S
Gastroenterology
. 2023 Apr;
165(2):492-495.e2.
PMID: 37030335
No abstract available.
6.
Ahmad H, East J, Panaccione R, Travis S, Canavan J, Usiskin K, et al.
J Crohns Colitis
. 2023 Feb;
17(8):1342-1353.
PMID: 36812142
Artificial intelligence shows promise for clinical research in inflammatory bowel disease endoscopy. Accurate assessment of endoscopic activity is important in clinical practice and inflammatory bowel disease clinical trials. Emerging artificial...
7.
Naegeli A, Hunter T, Dong Y, Hoskin B, Middleton-Dalby C, Hetherington J, et al.
Crohns Colitis 360
. 2023 Feb;
3(1):otab007.
PMID: 36777063
Background: Understanding ulcerative colitis disease activity assessed via the full, modified, or partial Mayo Score may help clinicians apply results from clinical trials to practice and facilitate interpretation of recent...
8.
Boden E, Canavan J, Moran C, McCann K, Dunn W, Farraye F, et al.
Crohns Colitis 360
. 2019 Aug;
1(2):otz009.
PMID: 31423487
Aim: The aim of this study was to determine the immunologic effects and safety of oral anti-CD3 in patients with ulcerative colitis (UC). Methods: An open-label pilot study of orally...
9.
Goettel J, Kotlarz D, Emani R, Canavan J, Konnikova L, Illig D, et al.
Cell Mol Gastroenterol Hepatol
. 2019 May;
8(2):193-195.
PMID: 31078723
No abstract available.
10.
Ouahed J, Gordon W, Canavan J, Zhou H, Du S, von Schack D, et al.
Inflamm Bowel Dis
. 2018 Aug;
24(12):2565-2578.
PMID: 30085215
Background: Transcriptional profiling has been performed on biopsies from ulcerative colitis patients. Limitations in prior studies include the variability introduced by inflammation, anatomic site of biopsy, extent of disease, and...